The quantitative level of T315I mutated BCR-ABL predicts for major molecular response to second-line nilotinib or dasatinib treatment in patients with chronic myeloid leukemia
Gespeichert in:
| Weitere Verfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2013
|
| In: |
Haematologica, the hematology journal
Year: 2013, Jahrgang: 98, Heft: 5, Pages: 714-717 |
| ISSN: | 1592-8721 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: http://www.haematologica.org/content/98/5/714
|
| Verfasserangaben: | Lange, Thoralf ... Mueller, Martin C. ... |
MARC
| LEADER | 00000caa a22000002c 4500 | ||
|---|---|---|---|
| 001 | 1493646680 | ||
| 003 | DE-627 | ||
| 005 | 20220811160601.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 141218s2013 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3324/haematol.2012.068890 |2 doi | |
| 035 | |a (DE-627)1493646680 | ||
| 035 | |a (DE-576)423646680 | ||
| 035 | |a (DE-599)BSZ423646680 | ||
| 035 | |a (OCoLC)1340655747 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 245 | 0 | 4 | |a The quantitative level of T315I mutated BCR-ABL predicts for major molecular response to second-line nilotinib or dasatinib treatment in patients with chronic myeloid leukemia |c Lange, Thoralf ... Mueller, Martin C. ... |
| 264 | 1 | |c 2013 | |
| 300 | |a 4 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am: 18.12.2014 | ||
| 700 | 1 | |a Lange, Thoralf |d 1970- |0 (DE-588)120204029 |0 (DE-627)08051975X |0 (DE-576)17837508X |4 oth | |
| 700 | 1 | |a Müller, Martin Christian |d 1972- |0 (DE-588)121360296 |0 (DE-627)705409236 |0 (DE-576)181482819 |4 oth | |
| 773 | 0 | 8 | |i In |t Haematologica, the hematology journal |d Pavia : Ferrata Storti Foundation, 2005 |g 98(2013), 5, Seite 714-717 |h Online-Ressource |w (DE-627)48524375X |w (DE-600)2186022-1 |w (DE-576)414771095 |x 1592-8721 |7 nnas |a The quantitative level of T315I mutated BCR-ABL predicts for major molecular response to second-line nilotinib or dasatinib treatment in patients with chronic myeloid leukemia |
| 773 | 1 | 8 | |g volume:98 |g year:2013 |g number:5 |g pages:714-717 |g extent:4 |a The quantitative level of T315I mutated BCR-ABL predicts for major molecular response to second-line nilotinib or dasatinib treatment in patients with chronic myeloid leukemia |
| 856 | 4 | 0 | |u http://www.haematologica.org/content/98/5/714 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20141218 | ||
| 993 | |a Article | ||
| 994 | |a 2013 | ||
| 998 | |g 121360296 |a Müller, Martin Christian |m 121360296:Müller, Martin Christian |d 60000 |d 61200 |e 60000PM121360296 |e 61200PM121360296 |k 0/60000/ |k 1/60000/61200/ |p 6 | ||
| 999 | |a KXP-PPN1493646680 |e 2827857170 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"given":"Thoralf","family":"Lange","role":"oth","display":"Lange, Thoralf"},{"display":"Müller, Martin Christian","role":"oth","family":"Müller","given":"Martin Christian"}],"title":[{"title_sort":"quantitative level of T315I mutated BCR-ABL predicts for major molecular response to second-line nilotinib or dasatinib treatment in patients with chronic myeloid leukemia","title":"The quantitative level of T315I mutated BCR-ABL predicts for major molecular response to second-line nilotinib or dasatinib treatment in patients with chronic myeloid leukemia"}],"language":["eng"],"recId":"1493646680","type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am: 18.12.2014"],"name":{"displayForm":["Lange, Thoralf ... Mueller, Martin C. ..."]},"id":{"eki":["1493646680"],"doi":["10.3324/haematol.2012.068890"]},"origin":[{"dateIssuedKey":"2013","dateIssuedDisp":"2013"}],"relHost":[{"id":{"eki":["48524375X"],"zdb":["2186022-1"],"issn":["1592-8721"]},"origin":[{"publisherPlace":"Pavia","dateIssuedDisp":"2005-2013","publisher":"Ferrata Storti Foundation","dateIssuedKey":"2005"}],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Haematologica, the hematology journal","title":"Haematologica, the hematology journal","subtitle":"official organ of the European Hematology Association"}],"part":{"extent":"4","volume":"98","text":"98(2013), 5, Seite 714-717","issue":"5","pages":"714-717","year":"2013"},"pubHistory":["90.2005 - 98.2013"],"language":["eng"],"recId":"48524375X","note":["Gesehen am 27.09.2018"],"disp":"The quantitative level of T315I mutated BCR-ABL predicts for major molecular response to second-line nilotinib or dasatinib treatment in patients with chronic myeloid leukemiaHaematologica, the hematology journal","type":{"media":"Online-Ressource","bibl":"periodical"}}],"physDesc":[{"extent":"4 S."}]} | ||
| SRT | |a QUANTITATI2013 | ||